NYSE$GMS

Gms Inc · Q3 2025 earnings

Q3 2025 earnings · · Before market open · Investor relations

Briefing

GMS reported Q3 2025 revenue of $1.26B, a net loss of $21.4M.

For Q3 2025, GMS reported Revenue was $1.26B, net loss was $21.4M. Management discusses segment trends, liquidity, and outlook in the quarterly filing.

  • Revenue $1.26B for Q3 2025.
  • Net loss $21.4M.
  • MD&A highlights operating priorities, liquidity, and sector risks.

Headline financials

Total Revenue

$1.26B

Previous: $1.26B+0.2%
EPS (adj)

$0.92

Previous: $1.60-42.5%
Gross Margin

31.2%

Previous: 33.0%-5.5%
Adjusted EBITDA

$93M

Previous: $128M-27.3%
SG&A Expense

$311M

Previous: $296M+5.1%
Net Debt / Adj. EBITDA

2.4

Previous: 1.5+60.0%
Net Income

-$21.4M

Previous: $51.90-41250581.7%
Operating Income

$4.78M

Previous: $87.8M-94.6%
Gross Profit

$393M

Previous: $415M-5.2%

Revenue & EPS history

GMS · Revenue · Quarterly

$1.26B

Q3 2025+0.2%vs Q3 2024
Beat estimate in 10 of 15 quarters(67%)
ActualEstimate

Forward guidance

Outlook emphasizes clinical milestones, liquidity runway, and operating expense discipline.

Tailwinds

  • Pipeline progress and partnership economics.
  • Cash supports near-term operating plans.

Headwinds

  • Operating losses until commercial scale.
  • Financing and trial outcomes affect funding costs.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 6 quarterly earnings reports · overlaid with Q3 2025

Historical avgQ3 2025

-0.3%

Avg return

Earnings day

+1.1%

Avg return

5 days after

+7.0%

Avg return

30 days after

45%

19 / 42 earnings

Positive

+24.8%

Q1 2020

Best reaction

-17.5%

Q3 2019

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q3 2026
Q2 2026
Q1 2026+0.0%+0.1%
Q4 2025+11.5%+38.0%+51.0%
Q3 2025-7.5%-10.7%-8.4%
Q2 2025-5.1%-7.2%-17.9%
Q1 2025-4.8%-7.9%-0.4%
Q4 2024-9.0%-11.0%+1.0%
Q3 2024+0.7%-1.1%+8.0%
Q2 2024-0.7%+8.3%+15.7%
Q1 2024-4.7%
Q4 2023+0.4%
Q3 2023-0.5%
Q2 2023+8.8%
Q1 2023-4.5%
Q4 2022+13.9%
Q3 2022-13.6%
Q2 2022+0.4%
Q1 2022+3.6%
Q4 2021+12.2%
Q3 2021+7.7%
Q2 2021-9.4%
Q1 2021-11.5%
Q4 2020+3.5%
Q3 2020-4.4%
Q2 2020-3.1%
Q1 2020+24.8%
Q4 2019+17.5%
Q3 2019-17.5%
Q2 2019-5.1%
Q1 2019-6.4%
Q4 2018-12.3%
Q3 2018+5.1%
Q2 2018-1.1%
Q1 2018+8.7%
Q4 2015+1.4%
Q4 2017-10.8%
Q3 2016+3.1%
Q3 2017+3.1%
Q2 2016-1.8%
Q2 2017-1.8%
Q1 2017-3.8%
Q1 2016-3.8%
Q4 2016+3.7%
Q3 2015
Q2 2015
Q1 2015

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro